Date updated:06-03-2009
Mike Huckman, a CNBC business reporter, came on the show to talk about the upcoming American Society of Clinical Oncology meeting.

-
OSIP
Osi Pharmaceutica - $33.32
- +0.54%
- $32.77
Huckman said some of the companies to watch are OSI Pharma(OSIP) which is expected to release test results on a cancer drug this weekend, and Medivation(MDVN), which is due to come out with some prostate cancer drug results.

-
MDVN
Medivation - $28.30
- +2.83%
- $27.98
Huckman said some of the companies to watch are OSI Pharma(OSIP) which is expected to release test results on a cancer drug this weekend, and Medivation(MDVN), which is due to come out with some prostate cancer drug results.

-
GHDX
Genomic Health - $20.08
- -0.84%
- $20.17
Genomic (GHDX) will introduce a test that may be able to determine the likelihood of colon cancer coming back and Astra-Zeneca (AZN) is expected to offer data on 3 different cancer drugs.

-
AZN
Astrazeneca Plc A - $44.98
- +0.11%
- $44.28
Genomic (GHDX) will introduce a test that may be able to determine the likelihood of colon cancer coming back and Astra-Zeneca (AZN) is expected to offer data on 3 different cancer drugs.
- Fast Money's Cancer Breakthrough Stocks's Blog
- No Blogs Found
- Top Professional Portfolios
- 1. Navellier & Associ...
- 2. Fidelity Contrafund - ...
- 3. Argus Management
- 4. WisdomTree Intl Consum...
- 5. Charlie Munger
- show all
- Top Do-It-Yourself Portfolios
- » John Shier
- » Joy
- » tsamanuli Portfolio 1
- » brueckenc Portfolio 1
- » Fundsonly Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...
By Roberto Pedone Posted on Nov. 5, 2009 The traders on CNBC’s “Fast Money” told their viewers what they must know after Warren Buffett announced on Tuesday his l...
By Jonas Elmerraji Posted on Nov. 4, 2009 For investors who seek out short-squeeze opportunities, there’s no time as important as earnings season. Earnings are one of...
By Stockpickr Staff Posted on Nov. 4, 2009 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is...
A. Also dont like that it has relations
with the god aweful never profitable
automobile industry, but is moving its
resources to the building side and
conserving energy for them.
A. The only one I own : SLX,
too hard pick a winner out all of them
These are some of the stocks mentioned on TheStreet.com TV on Sept. 2. Click the URL below each stock to watch the videos. more
These are the stocks from Jim Cramer's Oct. 30 Lightning Round. We list the stocks on which he is BULLISH and BEARISH.... more
Here are some stocks that moved up on unusual volume on Nov. 2, 2009. more











Comments not available